25 Feb
2019
17:00 E.S.T.

Cellectis Publishes Novel Methods to Improve the Safety of CAR T-Cell Therapy and Prevent CRS in the Journal of Biological Chemistry

Read more

10 Dec
2018
16:30 E.S.T.

Cellectis Appoints William Monteith as Senior Vice President U.S. Manufacturing

Read more

13 Nov
2018
16:30 E.S.T.

Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2018

Read more

19 Sep
2018
16:30 E.S.T.

CAR-T Pioneer Dr. Stephan A. Grupp to Join Cellectis Clinical Advisory Board

Read more

18 Sep
2018
16:30 E.S.T.

Calyxt Appoints CEO, Jim Blome,  Former President & CEO of Bayer CropScience LP

Read more

22 Aug
2018
08:00 E.S.T.

Calyxt Names Biotech Veteran and Board of Directors Member Dr. Yves J. Ribeill as Interim CEO

Read more

02 Aug
2018
16:30 E.S.T.

Cellectis Appoints Stefan Scherer M.D., Ph.D., as Senior Vice President Clinical Development and Deputy Chief Medical Officer

Read more

01 Aug
2018
16:30 E.S.T.

Cellectis Reports Financial Results for 2nd Quarter and First Six Months 2018

Read more

27 Jun
2018
16:30 E.S.T.

Cellectis S.A. Reports Results from Annual General Meeting Held on June 26, 2018

Read more

12 Jun
2018
16:30 E.S.T.

Cellectis Publishes Novel Methods to Improve the Clinical Use of Chimeric Antigen Receptor T-Cell Therapy in Scientific Reports

Read more